Blood News and Research

RSS

Stopping illicit steroids associated with depression and sexual dysfunction in men

Men who illicitly used steroids to boost muscle size and physical performance and have stopped in the past year have impaired sexual function compared with men currently using steroids, according to a study being presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Long-term study reveals safety of metformin use during pregnancy

Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Tirzepatide treatment results in successful weight loss regardless of obesity-related complications

Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

GLP-1 drugs may reduce pancreatitis risk in obese and diabetic patients

Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a study presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Breakthrough male contraceptive gel shows rapid results in clinical trial

Male contraceptive gel combines hormones for faster sperm production suppression.

3 Jun 2024

Excellent control of type 1 diabetes doesn't guarantee protection from heart disease

People who have had type 1 diabetes for more than 50 years without kidney complications may still be at substantial risk for heart disease, despite excellent control of blood pressure, cholesterol and blood sugar levels, according to a study presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial

Clinicians at Georgetown University's Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda).

3 Jun 2024

Canagliflozin enhances senescent cell clearance, improving aging-related conditions

Whether sodium-glucose co-transporter 2 (SGLT2) inhibitors induce senolysis.

3 Jun 2024

New strategy targets rare B cells for effective HIV vaccine development

Germline-targeting epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human immunodeficiency virus (HIV).

3 Jun 2024

Chronic caffeine intake may impact brain chemistry in Parkinson's disease

Regular high caffeine consumption affects dopamine function in patients with Parkinson’s disease, shows a new international study led by the University of Turku and Turku University Hospital in Finland. Caffeine consumption before undergoing diagnostic brain dopamine imaging may also affect the imaging results.

3 Jun 2024

US DoD funds Australian research on Parkinson's disease treatments

Researchers based at Australia’s Translational Research Institute (TRI) have received major funding from the United States Department of Defense (DoD) to develop Parkinson’s disease (PD) treatments by targeting the gut microbiome.

3 Jun 2024

New report highlights the urgent need for increased investment in MS research

A new report has revealed the prolonged time to diagnose multiple sclerosis (MS) and highlighted the urgent need for increased investment in MS research and enhanced awareness of the disease.

3 Jun 2024

Garlic proves potent in reducing blood sugar and cholesterol, study reveals

Study confirms garlic's significant benefits in lowering blood glucose and lipid levels, offering a natural remedy for metabolic disorders.

2 Jun 2024

Long-term health risks linger for severe COVID-19 patients three years after hospitalization

Three years after severe COVID-19 hospitalization, significant risks of mortality and long-term symptoms persist, impacting overall health and quality of life.

2 Jun 2024

Type 2 diabetes linked to higher cancer risk, especially with diabetic retinopathy, study finds

A recent study in BMC Medicine found that type 2 diabetes significantly increases the risk of various cancers, with the risk being even higher in patients with diabetic retinopathy (DR).

2 Jun 2024

Omega-3 supplements show promise in battling osteoarthritis

A recent study in Nutrients reviewed the efficacy of omega-3 polyunsaturated fatty acids (PUFAs) in slowing the progression of osteoarthritis (OA) by reducing inflammation and supporting joint health.

2 Jun 2024

Intermittent fasting with protein pacing trumps calorie restriction in gut health and weight loss

A recent study in Nature Communications found that intermittent fasting with protein pacing (IF-P) is more effective than continuous calorie restriction (CR) in improving gut microbiota and metabolomic profiles, leading to greater weight and fat loss.

2 Jun 2024

Study challenges use of in-hospital mortality as sepsis quality metric for safety-net hospitals

Sepsis is a leading cause of death and disability and a key target of state and federal quality measures for hospitals.

31 May 2024

New vessel-chip deployment platform holds promise for personalized drug testing

The pharmaceutical drug development and approval process is a multi-step undertaking that requires a plethora of testing before reaching the market.

31 May 2024

Stress and pain linked to worse outcomes in HER2-positive breast cancer patients

Secondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who reported high levels of pain and stress were more likely than their study peers to experience worse invasive disease-free survival (iDFS) and worse overall survival (OS).

31 May 2024

Previous
1
...
4
5
6
7
8
9
10
...
3533
Next

Blood News and Research

Stopping illicit steroids associated with depression and sexual dysfunction in men

Long-term study reveals safety of metformin use during pregnancy

Tirzepatide treatment results in successful weight loss regardless of obesity-related complications

GLP-1 drugs may reduce pancreatitis risk in obese and diabetic patients

Breakthrough male contraceptive gel shows rapid results in clinical trial

Excellent control of type 1 diabetes doesn't guarantee protection from heart disease

Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial

Canagliflozin enhances senescent cell clearance, improving aging-related conditions

New strategy targets rare B cells for effective HIV vaccine development

Chronic caffeine intake may impact brain chemistry in Parkinson's disease

US DoD funds Australian research on Parkinson's disease treatments

New report highlights the urgent need for increased investment in MS research

Garlic proves potent in reducing blood sugar and cholesterol, study reveals

Long-term health risks linger for severe COVID-19 patients three years after hospitalization

Type 2 diabetes linked to higher cancer risk, especially with diabetic retinopathy, study finds

Omega-3 supplements show promise in battling osteoarthritis

Intermittent fasting with protein pacing trumps calorie restriction in gut health and weight loss

Study challenges use of in-hospital mortality as sepsis quality metric for safety-net hospitals

New vessel-chip deployment platform holds promise for personalized drug testing

Stress and pain linked to worse outcomes in HER2-positive breast cancer patients

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Latest News